CVR: 40169229
Secondary names: Zerion A/S
Previous names: Zerion ApS, Zerion Pharma ApS
Zerion Pharma A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Zerion Pharma ApS and Zerion ApS. The management consists of Ole Sylvester-Hvid Wiborg. The company's owners include Geelanie Rodriguez Briones, WIBORG INTERNATIONAL HOLDING ApS and Waterman ApS. In 2025, the company reported revenue of DKK 3,377,646 and a net result of DKK -10,830,354 compared with DKK -220,020 the year before. Equity amounted to DKK -3,511,410.
Zerion Pharma A/S is currently facing significant financial challenges, highlighted by consistent losses over the past five years. Revenue has shown slight fluctuations, with a peak of 3,559,956 DKK in 2023, but profitability remains a major concern, as evidenced by a loss of 11,101,891 DKK that year. The company's equity has deteriorated sharply, dropping from -866,830 DKK in 2021 to -13,730,512 DKK in 2023, indicating a precarious financial position. While operating in the pharmaceutical manufacturing sector, Zerion's negative profit margins and declining equity suggest a need for strategic reassessment to improve its financial health and market position.
AI-generated summary
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed med udvikling af lægemidler samt enhver i forbindelse hermed stående virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 3.4 mio. | -10.8 mio. | 11.1 mio. | -3.5 mio. | 10 | |
| 2024 | 3.5 mio. | -220 t. | 9.7 mio. | -2.3 mio. | 12 | |
| 2023 | 3.6 mio. | -11.1 mio. | 8.5 mio. | -13.7 mio. | 11 | |
| 2022 | 3.3 mio. | -18.9 mio. | 12.4 mio. | -10 mio. | 12 | |
| 2021 | 1.9 mio. | -11.1 mio. | 13.7 mio. | -867 t. | 8 | |
| 2020 | - | -3.5 mio. | 7 mio. | -1 mio. | 3 | |
| 2019 | - | -1.1 mio. | 1 mio. | 31 t. | 3 |
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringCompared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Contact info changed: new phone: 40968018, new email: [email protected], new website: www.zerion.eu (July 2, 2026).
Zerion Pharma A/S has published its annual report for 2025. Revenue came to DKK 3,377,646, and the net result was DKK -10,830,354.
Contact info changed: new phone: 40968018, new email: [email protected], new website: www.zerion.eu (May 12, 2026).
Contact info changed: new phone: 40968018, new email: [email protected], new website: www.zerion.eu (April 24, 2026).
Contact info changed: new phone: 40968018, new email: [email protected], new website: www.zerion.eu (April 14, 2026).
Zerion Pharma A/S has published its annual report for 2024. Revenue came to DKK 3,452,016, and the net result was DKK -220,020.
As of June 25, 2025, Geelanie Rodriguez Briones has joined the board of directors of Zerion Pharma A/S.
As of June 25, 2025, Lars Lykke Thomsen has left the board of directors of Zerion Pharma A/S.
As of June 24, 2025, Geelanie Rodriguez Briones has left the board of directors of Zerion Pharma A/S.
As of February 5, 2025, Geelanie Rodriguez Briones has joined the board of directors of Zerion Pharma A/S.
As of February 5, 2025, Geelanie Rodriguez Briones is registered as an owner of Zerion Pharma A/S with an ownership share of 5%.
Zerion Pharma A/S has published its annual report for 2023. Revenue came to DKK 3,559,956, and the net result was DKK -11,101,891.
As of June 28, 2024, Allan Stich has joined the board of directors of Zerion Pharma A/S.
As of September 18, 2023, Carl-Åke Carlsson has joined the board of directors of Zerion Pharma A/S.
As of September 18, 2023, Torsten Rüdiger Goesch has left the board of directors of Zerion Pharma A/S.
Zerion Pharma A/S has published its annual report for 2022. Revenue came to DKK 3,273,327, and the net result was DKK -18,857,318.
Zerion Pharma A/S has published its annual report for 2021. Revenue came to DKK 1,932,775, and the net result was DKK -11,134,049.
As of December 27, 2021, Ole Sylvester-Hvid Wiborg has left the board of directors of Zerion Pharma A/S.
As of December 14, 2021, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Zerion Pharma A/S.
As of December 14, 2021, BAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of Zerion Pharma A/S.
As of December 14, 2021, Lars Lykke Thomsen has joined the board of directors of Zerion Pharma A/S.
As of December 14, 2021, Dorte Juhl Arnbjerg has joined the board of directors of Zerion Pharma A/S.
On December 14, 2021, the company changed its name from Zerion Pharma ApS to Zerion Pharma A/S.
As of December 13, 2021, Lars Lykke Thomsen has left the board of directors of Zerion Pharma A/S.
As of May 12, 2021, Torsten Rüdiger Goesch has joined the board of directors of Zerion Pharma A/S.
Zerion Pharma A/S has published its annual report for 2020. Gross profit came to DKK 784,282, and the net result was DKK -3,477,649.
As of May 11, 2021, Torsten Rüdiger Goesch has left the board of directors of Zerion Pharma A/S.
As of May 6, 2021, Lars Lykke Thomsen has joined the board of directors of Zerion Pharma A/S.
As of May 6, 2021, Torsten Rüdiger Goesch has joined the board of directors of Zerion Pharma A/S.
As of May 6, 2021, Adam Jun Bohr has left the board of directors of Zerion Pharma A/S.
As of May 6, 2021, Peter Mohan Christiansen has left the board of directors of Zerion Pharma A/S.
As of May 6, 2021, Christian Bone Falk-Rønne has left the board of directors of Zerion Pharma A/S.
As of May 6, 2021, Korbinian Arthur Maria Löbmann has left the board of directors of Zerion Pharma A/S.
On February 15, 2021, the company changed its name from Zerion ApS to Zerion Pharma ApS.
Zerion Pharma A/S has published its annual report for 2019. Gross profit came to DKK -1,068,242, and the net result was DKK -1,050,624.
As of April 27, 2020, BAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of Zerion Pharma A/S.
As of October 10, 2019, Ole Sylvester-Hvid Wiborg has joined the board of directors of Zerion Pharma A/S.
As of October 10, 2019, Adam Jun Bohr has joined the board of directors of Zerion Pharma A/S.
As of October 10, 2019, Peter Mohan Christiansen has joined the board of directors of Zerion Pharma A/S.
As of October 10, 2019, Jorrit Jeroen Water has joined the board of directors of Zerion Pharma A/S.
As of October 10, 2019, Christian Bone Falk-Rønne has joined the board of directors of Zerion Pharma A/S.
As of October 10, 2019, Korbinian Arthur Maria Löbmann has joined the board of directors of Zerion Pharma A/S.
As of May 1, 2019, Mohan.dk ApS is registered as an owner of Zerion Pharma A/S with an ownership share of 5%.
As of February 25, 2019, WIBORG INTERNATIONAL HOLDING ApS is registered as an owner of Zerion Pharma A/S with an ownership share of 5%.
As of February 25, 2019, Waterman ApS is registered as an owner of Zerion Pharma A/S with an ownership share of 5%.
As of February 25, 2019, Running Man ApS is registered as an owner of Zerion Pharma A/S with an ownership share of 5%.
As of February 25, 2019, Bohring ApS is registered as an owner of Zerion Pharma A/S with an ownership share of 5%.
As of January 14, 2019, Ole Sylvester-Hvid Wiborg is registered as director of Zerion Pharma A/S.
Zerion Pharma A/S was founded on January 14, 2019.
Companies in the same industry and area
CVR 37812730
CVR 39315769
CVR 41257547
CVR 41372079
CVR 44931478
companydata.dk